Evidence map›Paper›PMID 41859603›Full record

ArticleCureus2026

Prevalence of Oropharyngeal Dysphagia in Adults With Type 2 Diabetes Mellitus.

Astrid E Rosero-Castillo, José Rosmal Cortés Ponce, Marco Antonio Mendez Saenz

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Astrid E Rosero-CastilloOtolaryngology - Head and Neck Surgery, Universidad Autónoma de Nuevo León, La Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González", Monterrey, MEX.
José Rosmal Cortés PonceOtolaryngology - Head and Neck Surgery, Universidad Autónoma de Nuevo León, La Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González", Monterrey, MEX.
Marco Antonio Mendez SaenzOtolaryngology - Head and Neck Surgery, Universidad Autónoma de Nuevo León, La Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González", Monterrey, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Type 2 diabetes mellitus (T2DM) is a metabolic disease with high prevalence and multiple complications, including diabetic neuropathy, which can interfere with the swallowing process, causing dysphagia and increased morbidity and mortality. The Eating Assessment Tool-10 (EAT-10) questionnaire is a validated and sensitive tool for the clinical screening of dysphagia in asymptomatic population. Materials and methods This is a descriptive and prospective study that included 69 patients over the age of 18 diagnosed with T2DM, with no neurological or surgical history affecting swallowing. The validated Spanish version of the EAT-10 questionnaire was administered, considering dysphagia to be a score ≥3. Demographic variables, duration of diabetes, and treatment were recorded and analyzed using inferential and descriptive statistics with a significance level of p≤0.05. Results A total of 69 patients were involved in the study, 44 (63.8%) of whom were women. The mean age was 54.7 years and the average duration of T2DM was seven years. A prevalence of dysphagia was found in 16 patients (23.2%), with no significant difference between this diagnosis and the variables of age, sex, or duration of the disease (p≤0.05). The most frequently affected items on the EAT-10 were those related to effort when swallowing and a sensation of residue in the throat. Conclusion Nearly a quarter of the patients with T2DM evaluated showed signs consistent with oropharyngeal dysphagia. The results reinforce the value of the EAT-10 as a rapid, inexpensive, and noninvasive screening tool for detecting subclinical swallowing disorders in the diabetic population.

Indexed as

diabetic neuropathyeat-10oropharyngeal dysphagiascreening toolswallowing impairmenttype 2 diabetes

Identifiers

PMID41859603
PMCPMC12998400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.